Article

pacbiztimes.com on 2017-12-27 02:21

Amgen says repatriating earnings held overseas to cost it $6B in taxes

Thousand Oaks-based biotech giant Amgen said repatriating earnings held overseas is likely to cost it between $6 billion and $6.5 billion in taxes.

Related news